IL15 and Merkel cell skin cancer: Studies such as the QUILT 3.009 and QUILT 3.063 trials were underway to assess the efficacy of activated NK cells and IL-15 agonists in MCC that is at an advanced stage or has progressed after ICI, but both studies have since been terminated due to low recruitment [32,33].